Enovis Announces First Quarter 2025 Results

Financial Performance - Enovis reported first-quarter net sales of $559 million, reflecting an 8% increase on a reported basis and a 9% increase on a comparable basis year-over-year [2] - The Reconstructive segment saw net sales growth of 11% on both a reported and comparable basis, while the Prevention & Recovery segment grew by 5% on a reported basis and 7% on a comparable basis [2] - The company experienced a net loss from continuing operations of $56 million, equating to a loss of 10.0% of sales, with adjusted EBITDA of $99 million, representing a margin of 17.7% [3] Management Commentary - The CEO of Enovis stated that the company had a strong start to 2025, with revenues and margins exceeding expectations, attributing this performance to the strength of their business system and disciplined execution [4] Financial Outlook - Enovis updated its 2025 revenue expectations to a range of $2.22-2.25 billion, up from previous expectations of $2.19-2.22 billion, while adjusted EBITDA is now forecasted to be $385-395 million, down from $405-415 million due to tariff impacts [5] Product Segments - The first-quarter sales growth in the Prevention & Recovery segment was 5.2%, while the Reconstructive segment achieved a growth rate of 11.3% [39] - The U.S. Reconstructive sales grew by 11.4%, and international Reconstructive sales increased by 11.1% [39] Non-GAAP Financial Measures - Adjusted net income from continuing operations for the first quarter was reported at $46.5 million, with an adjusted net income margin of 8.3% [21] - The adjusted EBITDA margin increased by 160 basis points compared to the prior year, indicating improved operational efficiency [3][20]